Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-05

FDA Approved: NORETHINDRONE ACETATE — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for norethindrone acetate, allowing Ingenus Pharmaceuticals, LLC to market a generic norethindrone acetate product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norethindrone acetate (Norethindrone acetate)

Snippet

ORIG AP for NORETHINDRONE ACETATE (NORETHINDRONE ACETATE)